Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    Lingo-1
Show Display Options
Rank Status Study
1 Active, not recruiting Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Condition: Multiple Sclerosis
Interventions: Drug: BIIB033 (anti-LINGO-1 mAb);   Other: Placebo;   Drug: Interferon Beta-1a
2 Completed 215ON201 BIIB033 In Acute Optic Neuritis (AON)
Condition: Acute Optic Neuritis
Interventions: Biological: BIIB033 (anti-LINGO-1 mAb);   Drug: Placebo
3 Completed BIIB033 Single Ascending Dose Study in Healthy Volunteer Subjects
Condition: Healthy
Interventions: Drug: BIIB033;   Drug: Placebo
4 Completed Safety Study of BIIB033 in Subjects With Multiple Sclerosis
Conditions: Relapsing-Remitting Multiple Sclerosis;   Multiple Sclerosis
Interventions: Drug: BIIB033;   Drug: Placebo

Indicates status has not been verified in more than two years